Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about JAK2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
JAK2 is a gene implicated in neurodegeneration research. Key relationships include: activates, therapeutic target, inhibits. Associated with ALS, Aging, Als. Connected to 467 entities in the SciDEX knowledge graph.
| Gene Symbol | JAK2 |
| Aliases | Page for JAK2 Gene |
| Chromosome | 9p24.1 |
| Protein Type | Receptor |
| Function | is a critical non-receptor tyrosine kinase that mediates cytokine receptor signaling and plays essential roles in immune regulation, hematopoiesis, and cellular stress responses. |
| Primary Expression | neurons, astrocytes, microglia, and oligodendrocytes, where it participates in neuroinflammation, synaptic |
| Molecular Weight | 130 kDa |
| Amino Acids | 1132 aa |
| Pathways | JAK-STAT, JAK-STAT pathway |
| GeneCards | JAK2 |
| Human Protein Atlas | JAK2 |
| Drug | Specificity |
| Ruxolitinib | JAK1/JAK2 |
| Tofacitinib | JAK1/JAK2/JAK3 |
| Baricitinib | JAK1/JAK2 |
| Associated Diseases | ALS, Alzheimer, Autoimmune, Cancer, Carcinoma |
| Known Drugs/Compounds | ruxolitinib, curcumin, Curcumin, BARICITINIB, dasatinib, CURCUMIN |
| Interactions | STAT5, PDGFRB, CSF1R, AKT, STAT3, PNP |
| KG Connections | 1065 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
JAK2["JAK2<br/>Janus Kinase 2"] -->|"activates"| STAT["STAT Signaling"]
JAK2 -->|"activates"| Inflammation["Inflammation"]
JAK2 -->|"activates"| Immune["Immune Response"]
JAK2 -->|"activates"| CSF1R["CSF1R"]
JAK2 -->|"regulates"| GFAP["GFAP"]
JAK2 -->|"regulates"| GPX4["GPX4"]
JAK2 -->|"inhibits"| AKT["AKT Pathway"]
JAK2 -->|"inhibits"| Apoptosis["Apoptosis"]
JAK2 -->|"inhibits"| Endocytosis["Endocytosis"]
ABL1["ABL1"] -->|"activates"| JAK2
ABL2["ABL2"] -->|"activates"| JAK2
IL7R["IL7R"] -->|"contributes to"| JAK2
EPOR["EPOR"] -.->|"contributes to"| JAK2
JAK2 -->|"inhibits"| Alzheimer["Alzheimer's Disease"]
JAK2 -->|"therapeutic target"| Cancer["Cancer"]
JAK2 -->|"activates"| Fibrosis["Fibrosis"]
JAK2 -->|"activates"| ALS["ALS"]
style JAK2 fill:#e74c3c,stroke:#c0392b,color:#e0e0e0
style STAT fill:#3498db,stroke:#2980b9,color:#e0e0e0
style Inflammation fill:#f39c12,stroke:#e67e22,color:#e0e0e0
style Alzheimer fill:#9b59b6,stroke:#8e44ad,color:#e0e0e0
style Cancer fill:#9b59b6,stroke:#8e44ad,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Als | activates | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| Cancer | activates | disease | 1.00 |
| CANCER | activates | gene | 1.00 |
| Tumor | activates | disease | 0.95 |
| Tumor | therapeutic_target | disease | 0.95 |
| STAT3 | phosphorylates | protein | 0.90 |
| STAT3 | activates | protein | 0.90 |
| Apoptosis | inhibits | pathway | 0.90 |
| ASTROCYTES | activates | gene | 0.90 |
| MICROGLIA | activates | gene | 0.90 |
| BCL-2 | upregulates | protein | 0.88 |
| Cancer | therapeutic_target | disease | 0.85 |
| Als | inhibits | disease | 0.85 |
| Aging | activates | disease | 0.85 |
| IL-6 | upstream_of | protein | 0.82 |
| osteoarthritis | causes | disease | 0.80 |
| STAT3 | treats | gene | 0.80 |
| neuroinflammation | inhibits | disease | 0.80 |
| TNF-α | activates | protein | 0.80 |
| JAK-STAT signaling | participates_in | pathway | 0.80 |
| apoptosis pathway | participates_in | pathway | 0.80 |
| AKT | therapeutic_target | gene | 0.80 |
| CANCER | therapeutic_target | gene | 0.80 |
| Apoptosis | activates | pathway | 0.80 |
| INFLAMMATION | inhibits | gene | 0.80 |
| Invasion | activates | pathway | 0.80 |
| Ischemia | activates | disease | 0.75 |
| Cancer | inhibits | disease | 0.75 |
| Tumor | inhibits | disease | 0.75 |
| Neuroinflammation | inhibits | disease | 0.75 |
| Carcinoma | activates | disease | 0.75 |
| Ischemia | inhibits | disease | 0.75 |
| Stroke | inhibits | disease | 0.75 |
| Neuroinflammation | activates | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| Carcinoma | associated_with | disease | 0.75 |
| Carcinoma | therapeutic_target | disease | 0.75 |
| Inflammation | causes | disease | 0.75 |
| Ischemia | regulates | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Breast Cancer | therapeutic_target | disease | 0.75 |
| Neurodegeneration | activates | disease | 0.75 |
| Cancer | regulates | disease | 0.75 |
| GFAP | regulates | protein | 0.72 |
| STAT1 | activates | protein | 0.70 |
| ferroptosis | activates | process | 0.70 |
| SLC7A11 | regulates | protein | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| STAT3 | activates | gene | 1.00 |
| LRWE | downregulates | compound | 0.95 |
| Jolkinolide B | binds_to | drug | 0.92 |
| ruxolitinib | inhibits | drug | 0.90 |
| Curcumin | inhibits | drug | 0.90 |
| CYTOKINES | activates | gene | 0.90 |
| AG490 | inhibits | drug | 0.85 |
| CD1D | phosphorylates | protein | 0.85 |
| STAT3 | therapeutic_target | gene | 0.80 |
| PI3K | therapeutic_target | gene | 0.80 |
| STAT3 | regulates | gene | 0.80 |
| APOPTOSIS | inhibits | gene | 0.74 |
| BAX | inhibits | gene | 0.70 |
| DLAT | activates | gene | 0.70 |
| EGFR | therapeutic_target | gene | 0.70 |
| TNF | activates | gene | 0.70 |
| TNF | inhibits | gene | 0.70 |
| EGFR | treats | gene | 0.70 |
| GENES | activates | gene | 0.70 |
| APOPTOSIS | therapeutic_target | gene | 0.70 |
| OXIDATIVE STRESS | inhibits | gene | 0.70 |
| IL-6 | inhibits | gene | 0.70 |
| APOPTOSIS | activates | gene | 0.70 |
| CYTOKINES | inhibits | gene | 0.70 |
| IL-6 | activates | gene | 0.70 |
| FERROPTOSIS | activates | gene | 0.70 |
| HIF | activates | gene | 0.70 |
| NEURODEGENERATION | activates | gene | 0.70 |
| STAT3 | inhibits | gene | 0.66 |
| CX3CR1 | associated_with | gene | 0.65 |
| TREM2 | inhibits | gene | 0.65 |
| TNF | mediates | gene | 0.65 |
| NLRP3 | protects_against | gene | 0.65 |
| BARICITINIB | treats | drug | 0.65 |
| AXL | inhibits | gene | 0.65 |
| AMYLOID | associated_with | gene | 0.65 |
| ALZHEIMER | associated_with | gene | 0.65 |
| HEPATOCYTES | causes | cell_type | 0.65 |
| HEPATOCYTES | phosphorylates | cell_type | 0.65 |
| ERK | synergizes_with | gene | 0.65 |
| CURCUMIN | activates | drug | 0.65 |
| CURCUMIN | regulates | drug | 0.65 |
| MACROPHAGES | causes | cell_type | 0.65 |
| NEUROINFLAMMATION | degrades | phenotype | 0.65 |
| MICROGLIA | causes | cell_type | 0.65 |
| AUTOPHAGY | targets | phenotype | 0.65 |
| ROS | regulates | phenotype | 0.65 |
| ROS | phosphorylates | phenotype | 0.65 |
| MICROGLIA | inhibits | cell_type | 0.65 |
| MICROGLIA | promotes | cell_type | 0.65 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.507
neurodegeneration | 2026-04-01 | 20 hypotheses Top: 0.618
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||